Cogstate Limited Share Price
Stocks
CGS
AU000000CGS8
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Australian S.E.
05:11:03 12/11/2026 GMT
|
5-day change | 1st Jan Change | ||
| 3.760 AUD | +3.30% |
|
+11.24% | +66.37% |
| 10-12 | Cogstate Contracted Fiscal 2027 Revenue Rises to $56.8 Million After September Quarter Sales | MT |
| 09-25 | Morgans Financial Starts Cogstate at Buy with AU$4.07 Price Target | MT |
| Market Cap | 626M 429M 387M 357M 323M 611M 40.24B 4.28B 1.71B 21.55B 1.61B 1.58B 68.58B | P/E 2027 * |
28.9x | P/E 2028 * | 22.4x |
|---|---|---|---|---|---|
| Enterprise Value | 561M 385M 347M 320M 290M 548M 36.07B 3.84B 1.53B 19.32B 1.44B 1.41B 61.48B | EV / Sales 2027 * |
5.16x | EV / Sales 2028 * | 4.35x |
| Free-Float |
56.72% | Yield 2027 * |
1.37% | Yield 2028 * | 1.68% |
| Markets | Quality | ||
|---|---|---|---|
Australian S.E.
| CGS | Delayed | |
OTC Markets
| COGZF | Delayed | |
|
Deutsche Boerse AG
| C4B | Delayed | |
|
Boerse Muenchen
| C4B | Real-time |
Last Transcript: Cogstate Limited
| 1 day | +3.30% | ||
| 1 week | +11.24% | ||
| Current month | +8.99% | ||
| 1 month | -1.05% | ||
| 3 months | +36.73% | ||
| 6 months | +52.23% | ||
| Current year | +66.37% |
| 1 week | 3.22 |  | 3.84 |
| 1 month | 3.22 | | 3.95 |
| Current year | 2.01 | | 3.98 |
| 1 year | 1.75 | | 3.98 |
| 3 years | 0.8 | | 3.98 |
| 5 years | 0.8 | | 3.98 |
| 10 years | 0.16 | | 3.98 |
| Manager | Title | Age | Since |
|---|---|---|---|
Paul Maruff
CTO | Chief Tech/Sci/R&D Officer | - | 16/12/1999 |
Bradley O'Connor
CEO | Chief Executive Officer | - | 30/11/2005 |
Darren Watson
DFI | Director of Finance/CFO | - | 31/01/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
Bradley O'Connor
BRD | Director/Board Member | - | 28/02/2011 |
Martyn Myer
CHM | Chairman | 67 | 02/11/2009 |
Richard Mohs
BRD | Director/Board Member | - | 19/01/2017 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 30/10/26 | Free | Chief Executive Officer | 355,866 | 0.2061% | ||
| 29/10/26 | Exercice | Chief Executive Officer | -500,000 | 0.2907% | ||
| 29/10/26 | Sell | Chief Executive Officer | -500,000 | 0.2907% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.30% | +11.24% | +31.01% | +141.03% | 429M | |
| -1.06% | -0.07% | +60.76% | +68.61% | 67.53B | |
| +1.30% | +7.41% | +14.79% | +92.69% | 60.74B | |
| +0.39% | +0.30% | +20.04% | +98.33% | 55.66B | |
| -0.95% | +11.17% | +22.21% | +110.93% | 47.97B | |
| -0.23% | +4.07% | +25.63% | +40.08% | 45.24B | |
| -6.40% | -9.51% | +181.99% | +816.79% | 39.08B | |
| +1.97% | +3.50% | +25.78% | +50.98% | 35.34B | |
| -0.56% | -0.48% | +85.57% | +65.40% | 33.45B | |
| +1.05% | +9.77% | -37.66% | +408.42% | 26.49B | |
| Average | -0.12% | +2.39% | +43.01% | +189.33% | 41B | |
| Weighted average by Cap. | -0.48% | +1.65% | +44.29% | +169.11% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 109M 74.56M 67.2M 62.08M 56.12M 106M 6.99B 744M 297M 3.75B 280M 274M 11.92B | 125M 85.73M 77.27M 71.39M 64.54M 122M 8.04B 856M 341M 4.31B 322M 315M 13.7B |
| Net income | 21.75M 14.91M 13.44M 12.41M 11.22M 21.23M 1.4B 149M 59.29M 749M 55.95M 54.76M 2.38B | 27.77M 19.03M 17.15M 15.85M 14.33M 27.11M 1.79B 190M 75.7M 956M 71.43M 69.91M 3.04B |
| Net Debt | -64.78M -44.39M -40.01M -36.96M -33.41M -63.22M -4.16B -443M -177M -2.23B -167M -163M -7.1B | -82.32M -56.41M -50.84M -46.97M -42.46M -80.33M -5.29B -563M -224M -2.83B -212M -207M -9.02B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 12/11/26 | A$3.760 | +3.30% | 171,621 |
| 11/11/26 | A$3.640 | +1.11% | 683,685 |
| 10/11/26 | A$3.600 | +7.14% | 1,104,693 |
| 09/11/26 | A$3.360 | +2.13% | 220,119 |
| 06/11/26 | A$3.290 | -2.66% | 97,840 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CGS Stock
Select your edition
All financial news and data tailored to specific country editions
